Thermo Fisher Scientific Inc company logo

# RNN 1st Gen Model Thermo Fisher Scientific Inc Measuring & controlling devices, not elsewhere classified

Prediction models:
Subscribe >> Deal exit on
May 3, 2018
61.22% successful of 49 deals
$ 241.06 Last close price
at 16-nov-2018

TMO

Model's trade recommendations No return for period yet

0.53% Annual return

$83.91B Market Cap

β 1.14  

TMO

Model (following trade recommendations)

TMO

Underlying stock

S&P 500

Index
Return for period
6.77%
1.78%
52wk return 3.85%
26.76%
16.82%
52wk Range
182.03—248.51
2000.54—2399.63
Sortino ratio 0.08
Sharpe ratio 0.06
Norm. RMSE 0.46%
Downside risk 5.10%
Volatility 0.00%
  • 0.68 (0.33%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.

Industry sector: Medical

Sector classification: Measuring & controlling devices, not elsewhere classified

Deep Learning based analysis and prediction model for Thermo Fisher Scientific Inc (TMO) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for TMO model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 400M
P/E 21.09
Shares Outstanding 402M
% Held by Insiders 0.49%
% Held by Institutions 87.20%
EPS (last reported FY) $9.49
EPS (last reported Q) $2.50
EPS, estimated (last reported Q) $2.42
Total revenues $21 B
Net income $2 B